US Bancorp
CCCC icon

US Bancorp’s C4 Therapeutics CCCC Stock Holding History

US Bancorp’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,000
Closed -$15.7K – 4054
2025
Q2 		$15.7K Sell
11,000
-600
-5% -$873 ﹤0.01% 3264
2025
Q1 		$18.6K Buy
11,600
+11,544
+20,614% +$34.4K ﹤0.01% 3201
2024
Q4 		$202 Buy
56
+18
+47% +$90 ﹤0.01% 4083
2024
Q3 		$217 Buy
+38
New +$229 ﹤0.01% 4009
2024
Q2 		– Sell
-39
Closed -$319 – 3994
2024
Q1 		$319 Buy
+39
New +$302 ﹤0.01% 3885
2022
Q2 		– Sell
-118
Closed -$3K – 4091
2022
Q1 		$3K Buy
+118
New +$2.87K ﹤0.01% 3722

Other funds holding CCCC

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return